NRAS and cancer: We compared those data with NRAS mutations in cutaneous melanomas, hematopoietic and lymphoid tissue malignancies, and thyroid cancers from The Catalog of Somatic Mutations in Cancer (cancer.sanger.ac.uk) [35].